Bai Teng Zhao
Vermögen: 5 Mio $ am 31.07.2026
Vermögen: 5 Mio $ am 31.07.2026
Bai Teng Zhao was the founder of ProfoundBio (Suzhou) Co., Ltd., established in 2018, and held the titles of Chairman & General Manager from 2018 to 2024.
Currently, Dr. Zhao is a Director at Piton Therapeutics Inc and an Independent Director at Whitehawk Therapeutics, Inc. since 2024.
Dr. Zhao completed undergraduate studies at Peking University and earned a doctorate from The University of Texas at Austin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 1’250’000 ( 2.65% ) | 5 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.12.2024 |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
ProfoundBio (Suzhou) Co., Ltd.
ProfoundBio (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of novel targeted therapeutics | Vorstandsvorsitzender | 01.05.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProfoundBio (Suzhou) Co., Ltd.
ProfoundBio (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of novel targeted therapeutics | Commercial Services |
Aadi Bioscience, Inc.
Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen